Indian injectables maker KriGen to build $7M plant in North Carolina

B. Braun IV bags
KriGen Pharmaceuticals, an India-based injectables maker, unveiled plans to build a $7 million facility in Lillinton, North Carolina. (B.Braun)

KriGen Pharmaceuticals, an India-based injectables maker, unveiled plans to build a $7 million facility in Lillington, North Carolina.

The 55,000-square-foot facility will produce medical IV bags and injectables and create about 100 jobs. According to the company’s website, KriGen products currently include dextrose and sodium chloride IV bags.

“The vision of KriGen Pharmaceuticals is to improve the quality of human lives by providing affordable pharmaceutical formulations based on innovation and technology,” Dhruvkumar Patel, the company’s chief financial officer, said in a statement reported by WRAL TechWire.

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

The company is expected to receive a $200,000 grant from the One North Carolina Fund as part of an effort to attract KriGen to the state.

The company did not say when the project is expected to be completed.

A saline shortage due to production issues with a number of manufacturers since 2014 was exacerbated when hurricanes Irma and Maria wreaked havoc on pharma plants in Puerto Rico.

Suggested Articles

Boehringer Ingelheim has invested €225 million on inhaler production with a new plant in Spain and expanded lines in Germany.

Generic pain drug maker Lannett is closing its plant in Wyoming and laying off the remaining 80 employees.

Turkey is getting its first locally produced mAb via an Iranian biosimilars marker and the $100 million plant it built there.